Farm animals and aquaculture cryopreservation partnership announced
With the aim to jointly commercialise a global cryopreservation offering for farm animals and aquaculture, Vitrafy Life Sciences Limited has announced that it has entered a 12-month Strategic Commercial Agreement with IMV Technologies — a French-based multinational conglomerate with over 500 million animal inseminations annually.
In a statement about the agreement, Vitrafy said the partnership is designed to integrate its next-generation cryopreservation technology with IMV’s globally recognised offering. “This agreement with IMV Technologies represents a significant step in Vitrafy’s commercialisation strategy,” Managing Director and CEO Brent Owens said.
“By partnering with the global leader in animal reproduction, we accelerate the validation and adoption of our cryopreservation technology at scale,” Owens added. “This Agreement creates immediate revenue opportunities but also positions Vitrafy for long-term growth through global market access, while we continue to advance our human health strategy in North America.”
Oliver Kohlhaas, CEO of IMV Technologies, commented: “Vitrafy’s unique nitrogen-free cryopreservation technology has the potential to improve post-thaw cell viability. We are excited to collaborate with Vitrafy to offer even better solutions for our customers.”
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
